Sven Killi

Sven Killi

Company: Antion Biosciences SA

Job title: Chief Executive Officer


Reviewing Cell Multiplexing with the miCAR Platform 5:00 pm

• Leveraging multiplex engineering for the development of efficient, safe, and effective allogeneic cell therapies • Enabling simultaneous silencing of 6 genes and expression of a CAR/TCR in a single transduction step, with Antion’s miCAR platform • Yielding massive efficiencies, safety, and CoGs savings in allogeneic cell therapiesRead more

day: Day 1 – Track A – Evening

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.